July 14,2006

Chairman Grassley Questions CMS, FDA About Substituted Inhalation Drugs

Please see the printer-friendly version of Chairman Grassley's letter CMS and FDA regarding substituted inhalation drugs.

Next Article Previous Article

Recent News

04/03/25 Crapo Statement on Analysis Showing Economic Impact of Permanently Extending Trump’s Tax Cuts
04/02/25 Finance Committee Advances Bisignano to be SSA Commissioner
04/02/25 Crapo: FY 2025 Budget Resolution will Deliver Permanent Tax Relief, Spur Economic Growth and Restore Fiscal Order
04/01/25 Crapo Announces Hearing on the President’s Trade Agenda
04/01/25 Crapo Statement at Executive Session to Consider SSA Commissioner